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“Faith and reason are like two wings on which the human 
spirit rises to the contemplation of truth; and God has placed 
in the human heart a desire to know the truth—in a word, to 
know himself—so that, by knowing and loving God, men and 
women may also come to the fullness of truth about 
themselves“ 
(St. John Paul II, Fides et Ratio) 
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ABSTRACT 
Prostatic acid phosphatase (PAP) was discovered during the mid-1930s, but the 
molecular mechanisms in which this protein is involved remain poorly understood. 
This enzyme was originally described as a highly-expressed protein in the human 
prostate that was secreted to the seminal fluid. It has always been associated to 
prostate cancer, since high levels of acid phosphatase activity were found in the 
sera of patients with metastatic disease. Therefore, for 40 years, research was 
focused on the improvement of biochemical assays in an effort to find specific 
substrates for clinical application. However, in the 1980s PSA (prostate specific 
antigen) superseded PAP as a biomarker for early detection of the disease and 
became the preferred marker for diagnosis. Later, in the mid-1990s with the advent 
of new molecular techniques such as cloning and high-scale protein purification it 
was possible to obtain high-quality crystals for 3D-structural determinations of 
PAP. In addition, new concepts emerged concerning the physiological role of the 
enzyme, with renewed speculation regarding the molecular mechanisms in which 
this protein could be involved. The fact that the serum levels of the enzyme are 
increased in prostate cancer patients with metastatic disease rendered this enzyme 
an attractive target for immunotherapies against advanced prostate cancer. 
However, this hypothesis has thus far neglected the existence of any potential 
isoforms that could be expressed in other organs and tissues.  
Therefore, as part of this thesis, the molecular mechanisms where PAP is 
involved will be investigated. For this purpose, two biological tools were employed: 
a PAP-knockout mouse model and stable virus-transfected LNCaP cell lines. A 
novel transmembrane type-I isoform of PAP (TMPAP) was first characterized as a 
product of alternative splicing of the same gene (ACPP) that encodes for the well-
known secretory isoform (SPAP). TMPAP is distributed throughout mouse tissues, 
including prostate, lung, kidney, endometrium, salivary glands, and dorsal-root 
ganglia. The enzyme comprises an N-terminal domain containing the catalytic 
active site, a transmembrane helical domain, and a short C-terminal cytosolic 
domain that carries a tyrosine-based motif (Yxxφ) that targets the enzyme to the 
endosomal-lysosomal/exosomal pathway. This was confirmed by co-localization 
studies that revealed that PAP localizes to the plasma membrane as well as to the 
intracellular membranes of vesicles, lysosomes, and intraluminal vesicles of the 
multivesicular endosomes. Microarray experiments were performed on mouse 
tissues to study the differential gene expression profile between wild-type and PAP-
knockout mice. The differential gene expression that was observed between the 
prostates of wild-type and PAP-knockout mice suggested that PAP is involved in 
secretory mechanisms, as many genes related to this process appeared 
dysregulated. Moreover, the results obtained from two-hybrid system experiments 
suggested that snapin (a SNARE-associated protein) was a likely candidate protein 
that could interact with TMPAP. This interaction was recently proved by co-
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localization and florescence resonance energy transfer (FRET) studies. The PAP-
knockout mice developed prostate adenocarcinoma and showed dysregulation of 
genes related to vesicular traffic.  Consequently, this investigation was focused on 
murine submandibulary glands (SMG) as a model of an exocrine organ. The 
expression of PAP in SMG was found to be even higher than in mouse prostate. In 
addition to microarrays and miRNA analyses, physiological and biochemical 
determinations help to demonstrate that there is an increased salivation volume in 
PAP-knockout mice upon stimulation with secretagogue drugs. This supports the 
hypothesis that PAP is involved in the regulation of secretory and exocytic 
processes. PAP was found to account for 50% of the total acid phosphatase activity 
in male mouse saliva and it is expressed by the granular convoluted tubular cells of 
the male SMG but not by the acinar cells. Unlike prostate gland, however, the 
mouse SMG does not develop signs of hyperplasia or adenocarcinoma in spite of an 
observed increased acinar cell proliferation. This discrepancy was explained by 
studying the degree of lymphocyte infiltration, the dysregulation of miRNAs, and 
the differentially expressed genes in microarray data. In SMGs of PAP-knockout 
mice, the innate immune system was shown to be responsive and able to remove 
proliferating acinar cells, which may explain the absence of adenocarcinoma. In 
addition, the upregulation of anti-inflammatory molecules may prevent the 
extension of tissue damage. Finally, we compared the effect of the overexpression 
of SPAP and TMPAP in LNCaP cells with empty-vector cells. As a result, the 
TMPAP-LNCaP cells exhibited slower growth than SPAP-LNCaP or empty-vector 
cells. Cells overexpressing either SPAP or TMPAP isoform showed increased 2D-
projection area and increased HRP-uptake when compared with empty-vector cells. 
These two observations suggested an increased vesicular traffic in endo/exocytic 
pathways to maintain cell membrane homeostasis. Thus, vesicles loaded with 
TMPAP are most likely sorted to lysosomes by means of its Yxxφ motif. 
Consequently, there is an increased degradation of cargo molecules—such as 
receptor tyrosine kinases expressed on the cell surface—that could explain the 
observed slow growth of LNCaP cells that overexpress TMPAP. 
The molecular mechanisms identified in this study will definitely contribute to 
a better understanding of the physiological role of PAP in diseases and to a critical 
re-evaluation of existing immunotherapies. The knowledge of the molecular 
determinants responsible for the presence of TMPAP in the endo/exocytic pathway 
can also be exploited for the future development of radio-imaging and drug 
delivery protocols. 
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1 REVIEW OF THE LITERATURE 
1.1 Prostatic acid phosphatase and prostate cancer 
Prostatic acid phosphatase (PAP) is an enzyme highly expressed by the human 
prostate gland (Kutscher & Wolbergs 1935). It has been known in its soluble form 
since mid-1930s and it was associated to prostate cancer since high levels of the 
enzymatic activity are detected in serum of patients with metastasizing disease 
(Gutman & Gutman 1938). Nevertheless the molecular mechanisms behind this 
association remained poorly understood. One hypothesis postulates that the 
presence of PAP in serum is due to leakage from normal tissue due to the damage 
provoked by the cancerous cells. In addition, PAP activity was also detected in focal 
areas of bone metastasis (Bruce et al. 1980). Therefore, efforts have been focused in 
the development of clinical assays to determine the levels of PAP activity in serum 
towards the diagnosis of prostate cancer stage or recurrence. Since then the clinical 
laboratory methods evolved from colorimetric assays to radioimmunoassays (RIA) 
(Vihko 1978a; Griffiths 1983) with improved sensitivity and specificity. However, 
during the 1980s, the clinical use of PAP as biomarker was superseded by prostate 
specific antigen (PSA) that enabled the diagnostic of the disease in early stages 
(Stamey et al. 1987; Catalona et al. 1991). But in the last decade PSA 
determinations turned controversial due to the risk of over diagnosis (Draisma et 
al. 2003) that could lead to unnecessary treatment of patients that would never 
develop the disease. During the 1990s, a hypothesis emerged regarding the 
existence of a cytosolic cellular form (cPAP) of the enzyme. According to this 
hypothesis, cPAP has tumor-suppressor activity in prostate cancer cells by direct 
dephosphorylation of ErbB2 (an EGFR family member) (Lin & Clinton 1988; Lin et 
al. 1992). However, this hypothetical enzyme has never been cloned. The 
accumulation of results that could be better explained by a membrane associated 
form sparked the interest in the search for a potential alternative isoform (Vihko 
1979; Kontturi et al. 1988). The alternative cDNA transcript sequence (GenBank: 
BC007460.1) (Strausberg et al. 2002) found in biological databases and encoding 
for a histidine-acid phosphatase with high degree of sequence identity to the 
already known soluble form of PAP, finally led to focus into the characterization of 
this new transcript and its product. Furthermore, a signal peptide sequence of 32 
amino acids long present in the precursor of ACPP gene product that is absent in 
the mature form of the protein, confines the enzyme to the ER-Golgi-PM secretory 
route. The expression of a construct carrying a deletion of the signal peptide from 
hPAP sequence failed to lead to detectable levels of protein product (Hurt et al. 
2012). Finally, PAP-deficient mice slowly develop prostate adenocarcinoma in a 
way that resembles the stages of the human disease (Quintero et al. 2013).  
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1.2 Structure of prostatic acid phosphatase 
PAP is a histidine acid phosphatase characterized by the general signature 
motif RHGXRXP (Van Etten 1982). Other members of the family include the 
lysosomal acid phosphatase, the lysophosphatidic acid phosphatase, and the 
testicular acid phosphatase. According to the folding of the protein, PAP belongs to 
the phosphoglycerate mutase-like superfamily (Schneider et al. 1993). During the 
1980s and 1990s, a lot of effort was focused in structural studies and determination 
of the enzymatic mechanism (Van Etten 1982; Buchwald et al. 1984; Vihko et al. 
1993; Lindqvist et al. 1993; Schneider et al. 1993; Lindqvist et al. 1994; Porvari et 
al. 1994). The mass-production of recombinant protein in insect cells yielded 
suitable amounts of the enzyme for these crystallographic studies (Vihko et al. 
1993). The active enzyme is a dimer of molecular weight ca. 100 kDa (Ostrowski & 
Rybarska 1965) that shows positive cooperativity upon substrate binding (Luchter-
Wasylewska 2001). The active site of each subunit lies in the cleft between an α/β 
domain and an α-helical domain.  
The reaction pocket is formed by arginine residues (Arg11 and Arg15 that 
belongs to the histidine acid phosphatase signature motif RHGXRXP and Arg79) 
(Schneider et al. 1993). These positive-charged residues provide a stabilizing 
environment that contributes to the positioning of the negative-charged phosphate 
group of the substrate. The mechanism of hydrolysis is a two-step mechanism with 
a first step represented by a concerted SN2 mechanism that involves the histidine 
residue His12 as the nucleophile to form a phosphohistidine intermediate and a 
second rate-limiting step where the aspartic acid residue (Asp258)—as a general 
acid-base catalyst—assists in the release of the alcohol molecule (Porvari et al. 
1994; Sharma et al. 2008; Sharma & Juffer 2009) (Figure 1).  The presence of 
aliphatic alcohols in the reaction media may enhance the phosphohydrolase activity 
of the enzyme by acting as a phosphate acceptor in a transphosphorylation reaction 
(Buchwald et al. 1984; Valcour et al. 1989). 
The active site of PAP is big enough to accommodate different kinds of 
substrates as suggested by in vitro experiments (Schneider et al. 1993). The list of 
substrates that PAP dephosphorylates includes β-glycerophosphate, 
phosphorylcholine, lysophosphatidic acid, phosphoaminoacids, and nucleotides 
(Serrano et al. 1976; Vihko 1978b; Dziembor-Gryszkiewicz et al. 1978; Li et al. 
1984; Tanaka et al. 2004). The exact nature of the physiological substrates remains 
elusive, however. Only the direct dephophorylation of extracellular 5’-AMP by PAP 
has been demonstrated to be associated to the physiological mechanisms of pain 
sensing (Zylka et al. 2008). Recently, it was shown that TMPAP is the same enzyme 
known as thiamine monophosphatase (TMPase) (a.k.a. fluoride-resistant acid 
phosphatase, FRAP) (Zylka et al. 2008). Strikingly, thiamine monophosphate 
(TMP) is a very specific substrate of PAP as already observed in other studies about 
Review of the Literature 
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fluoride-resistant acid phosphatase (Knyihar-Csillik et al. 1986). During the 
structural characterization of rat PAP, the residues located at the entrance of the 
active site (Tyr123 and Arg127) were suggested to play a role in substrate specificity 
(Lindqvist et al. 1993; Porvari et al. 1994). These residues are not conserved in 
homologous lysosomal acid phosphatase (LAP) where they are replaced by lysine 
and glycine residues respectively (Lindqvist et al. 1993). Vanha-Perttula et al. 
observed that PAP and LAP exhibit differences in sensitivity to inhibition by L-(+)-
tartrate ion (Vanha-Perttula et al. 1972). When the sensitivity to inhibition by L-
(+)-tartrate was compared between rPAPTyr123Lys, Arg127Gly mutant and hLAP, the 
results indicated that both enzymes behave similarly toward concentrations of 
inhibitor greater than 10 mM. However, the enzymatic activity against the 
substrates such as p-nitrophenylphosphate, phosphocholine, or phosphocreatine 
was not greatly affected. This suggested that Tyr123 and Arg127 are not the only 
determinants for specificity in PAP (Porvari et al. 1994). 
 
Figure 1. Schematic representation of PAP mechanism based on Lindqvist et 
al. 1994. 
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1.3 Prostatic acid phosphatase as a 5’-ectonucleotidase 
and a thiamine monophosphatase 
The 5’-ectonucleotidase activity of PAP has been known for many years 
(Matsuda & Ogoshi 1966; Vihko 1978b; Randerath et al. 1989), but its role in 
purinergic signaling has been surprisingly overlooked. On the other hand, during 
the 1980s there was an effort to identify the hitherto unidentified enzyme called 
thiamine monophosphatase (TMPase, a.k.a fluoride-resistant acid phosphatase, 
FRAP) that was known as a marker for nociceptive neurons in dorsal root ganglia 
(DRG). Due to this property, it was thought that TMPase could have a role in 
nociception. Nevertheless, the gene encoding TMPase was never identified. During 
their studies, Dodd and co-workers reached the conclusion that TMPase could be 
the same secreted PAP enzyme—the only known isoform of PAP at the time—after 
biochemical identification of partially purified TMPase from rat DRG (Dodd et al. 
1983). However, later immunostaining studies using anti-PAP antibodies failed to 
identify PAP in the same locations where TMPase staining was known to be 
positive, and therefore made it impossible to assert that TMPase was indeed the 
secreted PAP (Dodd et al. 1983; Silverman & Kruger 1988). In 2008, Zylka et al. 
based on our findings, finally solved the open question and revealed that TMPase 
was the novel transmembrane isoform of PAP (TMPAP) (Quintero et al. 2007; 
Zylka et al. 2008; Taylor-Blake & Zylka 2010). Based on these two fundamental 
findings, subsequent rigorous studies finally established the role of the 5’-
ectonucleotidase activity of PAP in nociceptive circuits (Zylka et al. 2008; Sowa et 
al. 2010; Hurt & Zylka 2012).  
1.4 Homologous histidine acid phosphatases found in 
other organisms 
1.4.1 Histidine acid phosphatase of Francisella tularensis (FtHAP) 
The bacterial pathogen Francisella tularensis, which is the infectious agent 
responsible for the disease tularemia, expresses a histidine acid phosphatase 
known as FtHAP. Its closest structural homolog is hPAP in spite of sharing only 
27% amino acid sequence identity (Singh et al. 2009). The three-dimensional 
structure of FtHAP was determined in complex with inorganic phosphate ion (Pi), 
L-(+)-tartrate ion, and 3’-AMP as substrate (Singh et al. 2009). The 3’-AMP 
substrate was selected from in vitro experiments for which FtHAP exhibited the 
highest normalized activity. Interestingly, the authors developed a trapping mutant 
FtHAPAsp181Ala which locks the substrate 3’-AMP in the active site. This is a well-
established approach used to trap physiological substrates for protein-tyrosine 
phosphatases (PTPs) (Flint et al. 1997). In spite of the structural homology between 
both enzymes, the active site of FtHAP seems to be more compact than the active 
Review of the Literature 
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site of hPAP. This difference in size accounts for the increased specificity of FtHAP 
against 3’-AMP. Similar to PAP, the FtHAP structure is organized as a core α/β 
domain and a α-helical domain that caps the core domain (Singh et al. 2009). 
However, the most prominent difference between the folding of both enzymes 
resides in the different position of the first α-helix of the cap domain. This 
difference can be explained by means of the disulphide bond between Cys129 and 
Cys340 observed in hPAP structure that locks the α-helix away the entrance of the 
active site (Singh et al. 2009). In addition, in FtHAP the Tyr135 residue—located at 
the beginning of the first α-helix of the cap domain—and the Phe23 residue form a 
π-stacking interaction with the adenine ring of the substrate (Singh et al. 2009).  
These elements that are missing in hPAP are considered fundamental to the 
specificity of FtHAP towards 3’-AMP (Figure 2). 
1.4.2 Membrane-bound acid phosphatase of Trypanosoma brucei 
(TbMBAP) 
Trypanosoma brucei is the parasite responsible for the African 
trypanosomiasis, known as sleeping sickness in humans. This microorganism 
expresses two genes encoding transmembrane histidine acid phosphatases, 
TbMBAP1 and TbMBAP2, which are 58% identical and show 40% and 41% amino 
Figure 2. (A) Molecular overlay between hPAP (PDB: 2hpa, blue) and FtHAP (PDB: 3it1, orange). 
(B) Magnification view showing the active site sphere (translucent light-blue) with L-(+)-tartrate
ion inside from 2hpa structure along with the FtHAP Tyr135 and Phe23 residues (light-blue), and
the cap domains for hPAP (yellow) and FtHAP (purple). The cap domain in hPAP is locked in
position by a disulphide bridge (arrow). Based on (Singh et al. 2009). 
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acid identity to the well-characterized membrane bound acid phosphatase from 
Leshmania Mexicana (LmxMBAP), respectively (Engstler et al. 2005). 
Characterization studies revealed that 87±5% of the tartrate-sensitive acid 
phosphatase activity from T. brucei detergent extract corresponds to TbMBAP1. 
This protein shares 24% amino acid identity with human TMPAP (Engstler et al. 
2005). Unlike TMPAP, the C-terminus of TbMBAP1 does not contain a tyrosine-
based lysosomal targeting motif and the genes encoding the AP2 complex cannot 
be found in the trypanosome genome database. Therefore, this enzyme is absent in 
lysosomes, even in conditions of protein overexpression. The enzyme is present in 
recycling endosomes and it has been shown to be essential for the mainteinance of 
endo/exocytosis when expressed in the mammalian stage of the trypanosome 
(Engstler et al. 2005). 
1.5 Lysosomal biogenesis and function 
Lysosomes are membrane-enclosed cellular organelles at the intersection of 
exocytic and endocytic pathways that concentrate acid hydrolases in charge of 
degrading macromolecules. Therefore, two main cellular metabolic functions are 
attributed to lysosomes: the recycling of building blocks of material and the 
downregulation of cell signaling, both processes contributing to maintain cellular 
homeostasis (Luzio et al. 2007). In addition, lysosomal-related organelles (LROs) 
such as melanosomes, lytic granules, MHC class II compartments and platelet-
dense granules, are specialized forms of cell-type specific lysosomes that are 
involved in specialized protective functions (Dell'Angelica et al. 2000). Thereby, 
lysosomes were also observed to play a role in other fundamental processes such as 
autophagy, secretion, cell death, pathogen destruction—concomitant with antigen 
presentation—and plasma membrane-wound healing (Wileman 2013; Blank et al. 
2014; Andrews et al. 2014; Mrschtik & Ryan 2015). Lysosomes are characterized by 
an acidic lumen maintained at pH of 4.6-5.0 by proton-vacuolar pumping ATPases 
(Mellman et al. 1986).  Soluble lysosomal enzymes are synthesized in the rough 
endoplasmic reticulum along with other secretory proteins. The lysosomal enzymes 
are tagged with a mannose 6-phosphate group to differentiate them from the 
secretory proteins. Thereafter, the tagged molecules are packed in clathrin-coated 
vesicles and sorted from TGN to the endosomes by a receptor-mediated mechanism 
(M6PR) (von Figura & Hasilik 1986). Once the complex reach an endosome, it 
dissociates in the acidic environment and the receptor is recycled, whereas the 
ligand is delivered to the lysosomes. However, other lysosomal membrane 
associated proteins, such as lysosomal acid phosphatase (LAP), do not require a 
receptor-based trafficking mechanism and they can reach the lysosomes through 
either a direct or an indirect pathway that involves the plasma membrane and the 
endocytic route (Luzio et al. 2007). 
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1.6 Function of the tyrosine-based lysosomal targeting 
motif Yxxφ  
All cells interact with their environment by the export and import of substances 
through the plasma membrane via the mechanisms of endo/exocytosis. In 
particular, the main route of entry into the cell for many soluble molecules and 
membrane bound proteins is clathrin-mediated endocytosis (Sorkin & 
Puthenveedu 2013). Endocytosis is a fundamental mechanism, not only to import 
extracellular substances, but to maintain cell-membrane homeostasis and regulate 
cell-surface receptor signalling by internalization and sorting to degradation or 
recycling pathways.  
The process of formation of clathrin-coated vesicles (CCVs) has been 
extensively studied during the last decades. Clathrin is a cytosolic soluble protein 
that is attached to membrane lipids by heterotetrameric adaptor proteins (AP) that 
bind to both clathrin and phosphatidylinositol-4,5-diphosphate [PtdIns(4,5)P2], a 
lipid that is enriched in the inner leaflet of the plasma membrane (Sorkin & 
Puthenveedu 2013). The process continues with the recruiting of accessory proteins 
(Slepnev & De Camilli 2000) and the polymerization of clathrin to form clathrin-
coated pits (CCPs) on the intracellular side of the plasma membrane. Clathrin is a 
heterohexamer formed by light and heavy chains that adopts a conformation of 
triskelion that has the ability to form a three-dimensional lattice leading to the 
formation of buds and vesicles (Sorkin & Puthenveedu 2013). The heavy chains 
serve for structural purposes whereas the light chains provide regulatory functions. 
While the heavy chains are essential for the formation of vesicles (Huang et al. 
2004), the light chains are not indispensable for the general process of clathrin-
mediated endocytosis and it is thought that they play a role in the endocytosis of 
particular cargo molecules (Ferreira et al. 2012). 
The interaction between specific sorting sequences present in cargo molecules 
and adaptor proteins that also bind to clathrin concentrates cargo molecules in 
CCPs. Some proteins require the binding of the ligand to promote the binding to 
the adaptor protein (regulated endocytosis) whereas other proteins bind to the 
adaptor proteins irrespective of the ligand (constitutive endocytosis). For instance, 
in the case of receptor tyrosine kinases, the binding of the ligand produces a 
conformational change with a subsequent auto-phosphorylation of cytosolic 
tyrosine residues that promotes the binding of adaptor and accessory proteins, 
such as AP2, EPS15, and epsin, among others (Traub 2009). A typical example of 
constitutive endocytosis is showed by the transferrin receptor (TfR) where only the 
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presence of the tyrosine-based motif (Yxxφ) is sufficient to recruit the adaptor 
protein (Lampe et al. 2014). 
At present, the tyrosine-based endosomal-lysosomal targeting motif (Yxxφ) is 
one of the more studied sorting motifs (Sorkin & Puthenveedu 2013) found in many 
integral membrane proteins, such as lysosome-associated membrane glycoproteins 
(Lamp), lysosomal hydrolases (e.g. LAP), and nutrient receptors (e.g. TfR). The 
Yxxφ motifs bind to the μ-subunits of AP complexes (AP-1, AP-2, AP-3, AP-4 and 
AP-5). The different AP complexes participate in distinct intracellular routes. For 
instance, while the AP-1 complex is found associated to CCVs formed at TGN as 
part of the biosynthetic pathway, the AP-2 complex is the main adaptor protein 
complex found associated to CCVs that form at the plasma membrane. The AP-3 
complex participates in the transport of cargo proteins in the endo-lysosomal 
pathway, whereas the AP-4 complex takes part in the sorting of proteins to the 
basolateral surface in polarized cells.  The AP-5 complex has recently been 
described to be part of late endosome trafficking (Agrawal et al. 2013).  
In spite of the advances in the identification of molecular components that take 
part in the clathrin-mediated endocytic process, yet unanswered questions remain 
to be solved. For many of these components, still unidentified post-translational 
modifications can add a layer of modulation to the dynamics of the process as 
reviewed elsewhere (Bonifacino & Traub 2003). For instance, the phosphorylation 
of the tyrosine residue of the Yxxφ motif in the T-cell co-stimulatory receptor 
(CTLA4) upon activation blocks the interaction with the μ2 subunit of the AP2 
complex and inhibits the internalization of the receptor. In addition, the 
phosphorylated tyrosine residue recruits molecules for further signaling events. 
However, the phosphorylation of a serine residue at position Y-1 of the tyrosine-
based motif in AQP4 enhances the interaction with μ3A subunit and lysosomal 
targeting of the protein (Madrid et al. 2001).  
1.7 The SNARE complex and the mechanism of 
exocytosis 
Cellular compartmentalization is a fundamental characteristic of all eukaryotic 
cells. By keeping molecular components such as enzymes separated by lipid 
membranes, cell dynamics can be controlled in a spatial-temporal fashion. 
Compartmentalization also precludes the enzymatic activity to occur on incorrect 
substrates. The communication between different compartments is carried out by 
the trafficking of vesicles conveying the cargo molecules. This mechanism implies 
that the vesicles must fuse their membrane with the plasma membrane or the 
membrane of the target compartment (e.g. another vesicle or organelle) in order to 
deliver their cargo. This membrane fusion process is driven by the SNARE (soluble 
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N-ethylmaleimide sensitive factor attachment receptor) complex (Sollner et al. 
1993). SNARE proteins were identified in the late 1980s as part of the synapses in 
the brain (Trimble et al. 1988; Oyler et al. 1989; Inoue et al. 1992; Bennett et al. 
1992). The SNARE complex is formed when some components attached to the 
target membrane (e.g. syntaxin and SNAP25 in neuronal cells or the ubiquitously 
expressed SNAP23 in non-neuronal cells) bind to the vesicle associated membrane 
proteins (e.g. synaptobrevin). Even when the formation of the SNARE complex is 
sufficient for membrane fusion (Hu et al. 2003), other proteins can participate in 
the modulation of the process. Two important modulators are synaptotagmins that 
are calcium-sensor proteins (Geppert et al. 1994) and snapin which is a SNARE-
associated protein that facilitates the fusion event by enhancing the interaction 
between SNAP25 and synaptotagmin in neuronal cells and between SNAP23 and 
syntaxin in non-neuronal cells (Buxton et al. 2003).  
Several mechanisms have been described to explain the dynamics of regulated 
exocytosis. More precisely, in neuronal cells the presence of syanptotagmin (the 
Ca+2-sensor protein) complexed with SNAP25 triggers the fusion event of the 
docked vesicle. When Ca+2 ions bind to the synaptotagmin calcium-binding domain 
it promotes a conformational change that brings the vesicle membrane closer to the 
plasma membrane (Vrljic et al. 2010). In addition, the association between SNAP25 
and synaptotagmin is enhanced by PKA-dependent phosphorylation of snapin 
(Chheda et al. 2001). However, some integral membrane proteins, e.g. EBAG9, 
bind snapin resulting in inhibition of the PKA-dependent phosphorylation of 
snapin that results in a slowdown of the exocytic process (Ruder et al. 2005).   
1.8 Disturbed endocytosis as a hallmark of cancer 
In cancerous cells, normal physiological processes are hijacked to gain survival 
advantage compared to their normal counterparts. Endocytosis is an important 
mechanism for internalization, recycling or degradation of key mitogens such as 
RTKs. Therefore, a dysregulation on the endocytic mechanism is expected to 
impact in the dynamics of RTKs downregulation and other membrane molecules. 
Hence it will result in a sustained propagation of intracellular proliferation signals 
(Figure 3).  The changes in the overall appearance and dynamics of the plasma 
membrane suggest that dysregulated endocytosis is a hallmark of cancer (Mellman 
& Yarden 2013). At present, different endocytic mechanisms have been described. 
These include clathrin-mediated endocytosis (CME), caveolae-mediated 
endocytosis (CavME), clathrin- and caveolae-independent endocytosis, 
micropinocytosis, and circular dorsal ruffles (CDR) (Mosesson et al. 2008). All 
these mechanisms converge into lysosomes through several endosomal 
compartments. However, recycling mechanisms exist that allow internalized 
proteins to return back to the plasma membrane. One such example involves the 
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recycling of integrins, which is increased in tumour cells (Ramsay et al. 2007). 
Integrins are heterodimeric proteins responsible for the attachment of cells to the 
extracellular matrix (ECM). In humans there are at least 18 α and 8 β subunits that 
produce more than 24 αβ heterodimers. This structural variety accounts for the 
functional diversity of the integrin family (Shin et al. 2012). Integrins are type-I 
transmembrane glycoproteins that transmit information from the ECM to 
intracellular processes such as transcriptional regulation, cell proliferation, cell 
death, and cell migration.  
Recently, it has been suggested that endosomes can act as a signalling 
compartment in addition to be a sorting organelle towards recycling or degradation 
(Dobrowolski & De Robertis 2011). For instance, endocytosis is essential for Wnt 
signalling. In canonical Wnt signaling, the sequestration of GSK3 in intraluminal 
vesicles of MVEs leads to β-catenin accumulation and a consequent transcriptional 
Figure 3.  Disturbed endocytosis of transmembrane proteins contributes to loss of cell 
polarity, enhanced proliferation and cell migration. Reprinted by permission from Macmillan 
Publishers Ltd: Nature Reviews. Cancer. Nature Reviews.Cancer 8 (11): 835-850 , copyright 
(2008). 
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regulation of target genes (Taelman et al. 2010). On the other hand, in the non-
canonical Wnt signalling pathway, the frizzled receptor is internalized upon 
binding of Wnt and recruits Dishivelled2 (DVL2) which interacts with the μ2-
subunit of AP2 complex and leads to activation of small GTPases Rho and Rac (Yu 
et al. 2007).  
In particular, the endocytosis of EGFR has been extensively studied as a model 
of receptor—mediated endocytosis and different endocytic pathways were 
described for this particular RTK (Mosesson et al. 2008). After internalization, the 
EGFR can recycle back to the plasma membrane upon dissociation of the ligand in 
early endosomes (EE)—from where it can continue signaling (Dobrowolski & De 
Robertis 2011)—or it can follow a degradative pathway to lysosomes that requires 
the sorting of EGFR to the intraluminal vesicles (ILV) of MVE. This sorting 
mechanism is mediated by mono-ubiquitination of the receptor at the cell surface 
(Katzmann et al. 2002). The mono-ubiquitinated receptor interacts with the 
endosomal sorting complexes required for transport (ESCRTs) that along with 
other accessory proteins transfer the cargo to ILVs for subsequent degradation into 
lysosomes. However, under derailed endocytosis, the EGFR translocates to the 
nucleus where it can exert transcriptional regulation of gene expression. The 
aberrant nuclear localization of EGFR is observed in several epithelial carcinomas 
and determines a poor prognostic indicator (Bitler et al. 2010; De Angelis Campos 
et al. 2011). In addition, not all the proteins sorted into ILVs are mono-
ubiquitinated. For instance, the PAR1 receptor, a G protein-coupled receptor for 
thrombin, is sorted to the lysosomes independently of ubiquitination. Instead, 
PAR1 is sorted to ILVs by binding to the adaptor protein ALIX and the ESCRT-III 
complex. The binding between PAR1 is favored by the adaptor protein AP3 which 
binds to the tyrosine-based cytosolic motif (YxxL) of the receptor (Dores et al. 
2012). 
1.9 Mouse submandibular salivary glands as a model of 
exocrine organ 
In mammals, saliva is a fundamental biological body fluid that in addition to 
digestive enzymes contains other bioactive compounds (e.g. mucosal glycoproteins, 
antimicrobial components, immunoglobulins, growth factors, small peptides, and 
hormones) (Barka 1980). In this way, saliva plays an important role in keeping oral 
and digestive tract homeostasis. In animals other than humans it also contributes 
to wound healing through licking. In Mus musculus, the saliva also contains 
pheromones that mediates mate recognition when it is spread on pelage and the 
surroundings after grooming (Talley et al. 2001; Laukaitis et al. 2005).  
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In mammals the saliva is produced by a set of specialized major glands: the 
parotid, the submandibular and the sublingual glands which are innervated by the 
sympathetic and parasympathetic nervous systems. Additionally, the oral mucosa 
presents other minor glands that are disseminated throughout the oral cavity. The 
activation of adrenergic and cholinergic receptors associated to the sympathetic 
and parasympathetic nerves after stimulation produces the discharge of saliva from 
the glands. When both types of nerves are stimulated simultaneously, the amount 
of saliva discharged by the glands is greater than the corresponding individual 
stimulus (Proctor 1998). However, in the absence of any nerve stimulation small 
amounts of saliva are constitutively secreted (Proctor 1998).  
Upon stimulation the secretion is mainly produced in the acini constituted by 
the acinar cells which are the canonical secretory units of the gland. The fluid is 
collected by the secretory ducts, where its composition is further changed by 
mechanisms of active sodium reabsorption, addition of potassium ions and 
bicarbonate buffering which provides a final pH ranging from 7.6 to 10.0 in 
C57BL/6J mice (Ma et al. 1999; Ruiz-Ederra et al. 2009). This basic pH range is 
essential to prevent the formation of dental caries. The final composition of saliva 
depends on the stimulatory input signal as revealed by the fact that the activation 
of α-adrenergic receptors and muscarinic receptors are responsible for the 
electrolyte and fluid secretion with a modest protein secretion, while the β-
adrenergic stimulation produces protein secretion (Baum & Wellner 1999). In 
rodents, other peripheral input signals contribute to the stimulation of saliva 
secretion. These signals include chewing, olfaction, tasting, drinking, grooming, 
and heat exposure (Matsuo 1999; Proctor & Carpenter 2007). 
The submandibular gland (SMG) of the mice exhibits sexual dimorphism, a 
characteristic that is not present in humans (Junqueira & Fajer 1949; Treuting & 
Dintzs 2012). This sexual dimorphism is manifested by the development of the 
granular convoluted tubules (GCT) in male mice (Figure 4). In addition to the 
acini, the GCTs are exocrine structures that are fully developed after 4 weeks when 
they conform the ca. 19% of the gland volume in males, but only ca. 8% in female 
mice (Jayasinghe et al. 1990). The GCTs cells synthesize a variety of the biologically 
active peptides that are finally present in saliva. These bioactive molecules include 
nerve growth factor (NGF), epidermal growth factor (EGF), renin, erythropoietin, 
and kallikreins (Mori et al. 1992; Gresik 1994). In mice, the saliva secretion from 
SMG has proven to be more effective in wound healing through licking than the 
saliva from minor, sublingual and parotid glands (Bodner et al. 1991). 
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Figure 4. The sexual dimorphism present in SMG between female (A) and male (B) mice is
evidenced by the clear presence of granular convoluted tubules (GCT) in male mice. Black arrows 
indicate acinar cells. White arrows indicate GCT cells that are clearly differentiated in male but not 
in female mice. The pictures were taken with the same magnification. Adapted from Araujo et al.,
Prostatic acid phosphatase is the main acid phosphatase with 5’-ectonucleotidase activity in the 
male mouse saliva and regulates salivation, Am J Physiol Cell Physiol, 2014, 306: C1017-C1027. 
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2 AIMS OF THIS STUDY 
The principal focus of this doctoral investigation was to elucidate the molecular 
mechanisms in which the prostatic acid phosphatase (PAP) is involved. PAP 
belongs to the histidine-acid-phosphatase family and, for more than 70 years, only 
one secreted soluble isoform (SPAP) was known.  
The main goals of this study were: 
1. To characterize a novel transcript of PAP enzyme. 
 
2. To study the effects of PAP-deficiency in a mouse model at 
functional and gene expression levels.  
 
 
3. To study the effect of the overexpression of PAP isoforms in LNCaP 
cells.  
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3 MATERIALS AND METHODS 
3.1 Ethics statement 
The animal experimentation protocols were approved by the Animal 
Experimentation Committee of the National Animal Experiment Board of Finland 
(ELLA). The work was undertaken under the project license numbers ESLH-2009-
07019/Ym-23. 
3.2 Mice  
PAP-/- mice were generated by removing exon 3 (PAPΔ3/Δ3) of the prostatic acid 
phosphatase gene (Acpp), completely abolishing the expression of SPAP and 
TMPAP gene products (Vihko et al. 2005). PAP-/- mice have been backcrossed to 
the C57BL/6J strain (Harlan Laboratories) for 16 generations. They were analysed 
alongside age-matched C57BL/6J wild-type mice as controls. For tissue sampling, 
mice were killed by cervical dislocation and the SMG were immediately dissected 
unless otherwise specified. 
3.3 Stable transfected LNCaP cells 
Stably transfected LNCaP cells overexpressing TMPAP (LNCaP-TMPAP) and 
empty vector (LNCaP-pMX) were generated as described elsewhere (Quintero et al. 
2013). The same procedure and protocol was used to generate the virus-stable 
transfected LNCaP cells overexpressing SPAP (LNCaP-SPAP). The transfected 
LNCaP cells were grown and maintained in complete RPMI-1640 [RPMI-1640 
supplemented with 10% FCS, 2mM glutamine, and 100 U/ml penicillin, and 100 
μg/ml streptomycin (Sigma)]. Geneticin G418 (200μg/ml) was used for selection of 
transformed cells. Original cell line LNCaP clone FGC was obtained from ATCC cell 
bank. After transfection, each cell line was stored as stock in liquid nitrogen. The 
cryopreserved suspensions were resuscitated after 4 months. All the cell lines were 
routinely tested for +PSA (prostate specific antigen) and +PAP secretion. 
3.4 Bioinformatics determination of TMPAP sequence 
elements 
Sequence alignment amongst PAP and LAP sequences of rat, mouse and 
human species was done with ClustalW (Thompson et al. 1994). ESPript software 
(Gouet et al. 1999) was used for figures. PHD tool via PredictProtein server (Rost & 
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Liu 2003) was used to obtain secondary structure elements for ESPript software. 
Prediction of transmembrane segment was done with TMHMM 2.0 server (Kahsay 
et al. 2005) and signal peptide was predicted with SignalP server (Bendtsen et al. 
2004).  
3.5 Prediction of nucleotide sequence for rat TMPAP 
variant 
The nucleotide sequence for rat TMPAP variant was searched in a region of 
146307 bp from NCBI reference sequence NW_047801.1 by pattern matching 
implemented in a Perl script using a regular expression (G...{117}(TGA|TAG|TAA))—to 
match the region coding the C-terminus of the mouse variant—after the portion of 
the sequence that matches the first methionine and the following four amino acids 
(ATGAGAGCTGTCCCT). Matching sequences that contain an earlier stop codon or 
gaps by matching the regular expression pattern ^(G..)(...)*(TGA|TAG|TAA|NNN)(...)*(TGA|TAG|TAA)$ 
were disregarded. The obtained segments were translated to protein code and 
compared with the C-terminus of the mouse sequence. 
3.6 Microarray analyses 
Total RNA was isolated from SMG of two-month-old male PAP-/- and wild-type 
mice (8 per group), cut into four equal pieces and stored in RNA stabilization 
reagent (RNAlater, Qiagen). Each tissue fragment was lysed with Lysing Matrix D 
ceramic beads in LT buffer (Qiagen) with 2-mercaptoethanol (Sigma), using a 
FastPrep FP120 homogenizer (Thermo Savant). The four lysates were pooled and 
total RNA isolated with the RNeasy Midi kit (Qiagen) according to the 
manufacturer’s instructions. The microarray experiments were performed at the 
Functional Genomics Unit (FuGU), Biomedicum Helsinki by Two-Color 
Microarray-Based Gene Expression Analysis. Labeling and hybridization were 
performed according to the manufacturer´s instructions. Combined experimental 
and reference samples were mixed with blocking agent, fragmentation, and 
hybridization buffer, and hybridized to Agilent Mouse Genome Microarray 4x44K 
in dye-swap configuration, following the manufacturer’s instructions. Microarrays 
were washed and scanned with an Agilent Scanner, using protocols provided by the 
manufacturer. Feature Extraction software was used for image analysis. All control 
and saturated spots from the microarray data were excluded. The data were then 
subjected to linear normalization to allow comparison between arrays. 
Differentially expressed genes (DEGs) between PAP-/- and wild-type replicate 
samples were calculated using the median fold change (FC) value of the replicate 
pairs. DEGs with Benjamini and Hochberg FDR corrected p-value cut-off 0.05 were 
selected for further analyses (Ovaska et al. 2010; Development Core Team 2014). 
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Ontological analyses were performed using GoMiner software (Zeeberg et al. 
2003), and ontological groups with “p-value changed” less than 0.05 were 
considered as significant. Genes were considered significantly downregulated or 
upregulated with FC cut-off 1.5. Network analyses were made with GeneMANIA 
software (Warde-Farley et al. 2010). The INTERFEROME database (Rusinova et al. 
2013) was used to search for interferon regulated genes in DEGs list. The database 
was queried with parameters for in vivo experiments in Mus musculus with FC cut-
off 1.5. 
3.7 miRNA sequencing analyses of mouse SMG 
Total RNA was extracted from frozen 2-month-old male mouse SMG samples 
(4 animals per genotype) stored in RNAlater, using the miRNeasy kit (Qiagen) 
following the manufacturer’s protocol and stored at -70°C until further processing. 
Then, 1.0 μg of RNA was used for preparation of smallRNA libraries according to 
the user´s guide of the TruSeq Small RNA kit (Illumina). Library quality control 
was evaluated with an Agilent Bioanalyzer (Agilent Technologies). Caliper 
LabChipXT (PerkinElmer) was used for enrichment of miRNA containing 147 bp ± 
5% fraction from the smallRNA library amplification products. This fraction 
contains mature microRNAs generated from approximately 22 nt RNA fragments. 
The Illumina HiSeq platform was used for 50 bp PE sequencing of miRNA enriched 
libraries. The miRseq data were analyzed by the Institute for Molecular Medicine 
Finland (FIMM) miRseq analysis pipeline with the main inputs being metric plots 
and expression data. The FIMM miRseq analysis pipeline is a modified version of 
the miRNA analysis and expression profiling pipeline, E-miR, originally developed 
by Buermans et al. 2010. The Bowtie (Langmead et al. 2009) mature transcript per 
million (tpm) table was filtered for significantly (p-value < 0.05) dysregulated 
miRNAs by carrying out a t-test comparison between PAP-/- and wild-type Bowtie 
tpm. Fold-changes were calculated from the ratio between PAP-/- and wild-type 
mean values. 
3.8 TMP and AMP histochemistry of mouse SMG 
Wild-type and PAP-/- 2-month-old mice (3 per group) were anesthetized with 
Mebunat Vet (60 mg/ml, Orion Pharma) and intracardially perfused with 
phosphate buffer pH 7.4 (PB), followed by 4% PFA (paraformaldehyde) prepared in 
PB. SMG were post-fixed for 2 h in 4% PFA, then cryoprotected in 30% sucrose in 
PB. SMG were embedded in OCTTM (Tissue-Tek, Sakura). From these, 30 μm 
cryosections were prepared. Samples were assayed for PAP 5’-ectonucleotidase 
activity with TMP, AMP, ADP, and ATP substrates (Sigma-Aldrich) according to 
Knyihar-Csillik’s modified protocol (Knyihar-Csillik et al. 1986). Briefly, 
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cryosections were dried for 15 min at 37°C, washed twice with 0.04 M Trizma-
Maleate buffer (TMB) pH 5.6 and once with 8% (w/v) sucrose in TMB. The slides 
were then incubated for 2 h at 37°C in a solution containing 0.25% (w/v) substrate 
(TMP, AMP, ADP or ATP), 8% (w/v) sucrose, and 0.08% (w/v) Pb(NO3)2 in TMB. 
Subsequently, slides were washed for 1 min in 2% acetic acid, followed by 3 washes 
with TMB and development for 10 sec in 1% Na2S in TMB. Sections were then 
washed in H2O, dehydrated in an alcohol gradient and xylene, and mounted with 
Pertex (HistoLab Products AB). 
3.9 Measurement of total salivation volume under 
sympathetic and parasympathetic stimulation 
Two-month-old wild-type (17 males, 9 females) and PAP-/- (15 males, 8 
females) mice were weighed and then anaesthetized by intraperitoneal injection of 
a mixture of 10 mg/kg xylazin (Rompun® Vet 20 mg/ml, Bayer) and 36 mg/kg 
ketamine (Ketalar 50 mg/ml, Pfizer Oy) in sterile isotonic saline solution. After 
anesthetization, animals were intraperitoneally injected with a cocktail of 
secretagogues containing 2 mg/kg of (-)-isoproterenol hydrochloride (Sigma-
Aldrich) and 0.5 mg/kg of pilocarpine hydrochloride (99% titration, Sigma-
Aldrich). Five min after injection, the total saliva was collected in Eppendorf tubes 
on ice for 10 min, using a peristaltic pump at constant speed. The volume was 
determined with a micropipette. Samples were stored at -20°C for further analyses. 
The animals were assayed in small groups (4 to 5 animals) at the same time of the 
day to avoid differences in the salivation properties due to circadian rhythm. 
3.10 Determination of total protein concentration and α-
amylase activity in mouse saliva 
Total protein concentrations were measured in the saliva samples collected 
from stimulated mice with the Pierce BCA Protein Assay kit (Thermo) following the 
manufacturer’s instructions. The enzymatic assay to evaluate the α-amylase activity 
was performed, following a modified Sigma A3176-SSSTAR01 protocol adjusted to 
microscale. 
3.11 Assesment of GCT and acinar cell proliferation and 
apoptosis 
SMG of male PAP-/- and wild-type mice, aged 3, 6, and 12 months (4 mice per 
group) were fixed in formalin and the specimens were embedded in paraffin. To 
assess the degree of cell proliferation and apoptosis, sections (5 μm) were prepared, 
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deparaffinized, rehydrated and stained. To detect proliferating cells, a rabbit 
polyclonal anti-Ki67 antibody (AB15580, Abcam) and the Vectastain Elite ABC Kit 
(Vector Laboratories) with hematoxylin counterstaining were used. To detect 
apoptotic cells, terminal deoxynucleotidyl transferase–mediated dUTP nick end 
labeling (TUNEL) staining was conducted, using the FragEL DNA Fragmentation 
Detection Kit (Calbiochem) following the manufacturer’s instructions, and 
hematoxylin counterstaining. Ki67- and TUNEL-positive cells were quantified as 
follows: the sections were photographed with a Labovert FS microscope 
(magnification 40x), 10 random fields were captured for each section from non-
inflammatory areas. In each field, the total number of acinar and GCT cells, as well 
as the number of Ki67- and TUNEL-positive acinar cells, were counted. The acinar 
and GCT cells were discriminated based on their morphological differences that 
were readily identifiable under experimental conditions, without need for 
additional staining. The ratio of positive cells to the total amount of cells per 
sample was compared between PAP-/- and wild-type groups for each marker, using 
two-sample t-test for equality of proportions with continuity correction for each age 
group, as implemented in the R statistical package version 2.10.1. 
3.12 Determination of cell areas 
One frame from the IncuCyte videos taken from the plates containing 2500 or 
5000 cells/cm2 was extracted at 48h and the cell areas were measured using 
CorelDraw X6 software. The images were kept at the same dimensions for 
comparison. Polyline contours were manually drawn around cells avoiding round 
cells or cells clearly in division. The area value was then taken from the ‘area’ 
attribute of the polyline object in square-inches (in.2) and converted to μm2 using 
the scale bar on the pictures. The differences in mean values were compared for 
statistical significance by Mann-Whitney test. 
3.13 Cell-cyle analysis of LNCaP cells by flow cytometry 
LNCaP-TMPAP, -SPAP or -pMX cells were seeded at a density of 15000 
cells/cm2. Cells were then incubated for 24, 48, 72 or 96 h and a pulse with BrdU 
(final concentration 15 μM) for 60 min was given to the cells prior to trypsinization. 
Cells were washed with PBS and fixed with 70% ethanol. For the flow cytometry 
stain, cells were first washed with PBS, permeabilized in 0.1% Triton X-100 in PBS, 
and their DNA was denatured with 1 M HCl for 30 min.  After DNA denaturation, 
the cells were washed twice with 1% BSA in PBS and incubated 30 min antiBrdU-
FITC antibody (BD347583). The cells were washed again with 1% BSA in PBS and 
finally re-suspended in 5 μg/ml propidium iodine (Sigma P4864) solution in PBS. 
Samples were assessed in a BD AccuriC6 flow cytometer. Flow cytometry data files 
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in FCS format were exported to text file format using FCSTrans v1.3 conversion 
utility (Qian et al. 2012) and the resulting text files were imported into TOPCAT 
v4.1 software (Taylor 2005; Taylor 2006; Taylor 2009) for cell cycle analysis. The 
differences in mean values were compared for statistical significance by two-tailed 
Student’s t-test. 
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4 RESULTS 
4.1 Alternative splicing of Acpp gene produces a novel 
PAP transmembrane isoform 
 A high degree of homology was found between the cDNA sequence for the 
mouse TMPAP variant and the PCR products obtained from total RNA derived 
from human, mouse and rat tissues. The rat cDNA (GenBank accession no. 
DQ826426) exhibits 91% and 81% of identities with reported cDNA sequences of 
mouse (NM_207668) and human (BC007460) PAP, respectively (Roiko et al. 
1990; Strausberg et al. 2002). The analysis of the exon-intron junctions suggests 
that PAP variants originate from alternative splicing in rat, mouse and human. The 
position of the splicing of the 10th intron is similar at the end of the 10th exon. This 
splicing leads to the secreted variant mRNA in rat and mouse, and to the 
transmembrane variant in human. In mouse and rat, the splicing of the 10th intron, 
the 11th exon, and the 11th intron yields the transmembrane variant. In human, the 
secreted variant mRNA originates as a consequence of the absence of intron 10 and 
hence the open reading frame continues over the splicing site until the stop codon 
(Figure 5). The long isoform of the rat PAP was absent from biological databases; 
therefore a custom search was made of the rat genome. The nucleotide sequence 
Figure 5. Schematic representation of alternative splicing in Acpp gene for human, 
mouse and rat. Vertical red lines represent stop codons. 
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encoding the long isoform in the rat genome was found by using regular expression 
matching. Just one out of the 212 amino acid sequences encoded by the matched 
regular expression pattern exhibited 100% amino acid identity with the C-terminal 
part of mouse transmembrane isoform. 
4.2 The novel TMPAP isoform is a type-I transmembrane 
protein with a Yxxφ motif 
Sequence analysis of TMPAP revealed the presence of a transmembrane 
segment at the C-terminus followed by a short cytosolic tail. The arrangement 
between the first 32 amino acids (signal peptide) and the transmembrane segment 
defines the topology of the TMPAP isoform as a transmembrane type-I protein. 
Hence, the N-terminal domain carries the catalytically active site and the C-
terminus comprises a short cytosolic tail with a tyrosine-based motif (Yxxφ) at the 
end (Figure 7 and Figure 8). The Figure 6 shows the comparison of the C-
terminus sequence between PAP and lysosomal acid phosphatase LAP. The Figure 
7B shows phospho-serine/threonine and phospho-tyrosine motifs predicted in the 
short cytosolic tail of TMPAP.  
Figure 6. Comparison of C-terminal sequence of hPAP and hLAP toward protease activity. The 
different fragments generated by proteases acting on hLAP are showed in different colors. 
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Figure 7. (A) Alignment of PAP isoform sequences from human, mouse and rat. Only the N- and
C-terminus of TMPAP and SPAP isoforms are shown. Red arrowheads indicate potential 
phosphorylation sites of phosphobinding motifs detailed in B. Adapted by permission from the
American Association for Cancer Research: Quintero et al., Prostatic Acid Phosphatase Is Not a
Prostate Specific Target, Cancer Research, 2007, 67: (14), 6549-54. (B) Serine/threonine and
tyrosine motifs recognized by kinases, phosphatases and binding proteins (unpublished).  
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4.3 TMPAP is widely expressed and the ratio between 
PAP isoforms changes in prostate cancer 
RT-PCR experiments revealed that TMPAP was widely expressed in mouse 
tissues (e.g. prostate lobes, salivary gland, thymus, lung, kidney, brain, spleen, and 
thyroid, in addition to Schwann and fibroblast cells). Furthermore, the expression 
of SPAP variant was detected in mouse salivary gland, thymus, and thyroid. The 
SPAP and the TMPAP variants were detected in LNCaP cells but not in PC3 cells 
(Figure 9).  
Figure 8. Topological features in hTMPAP precursor sequence. N-terminus and C-
terminus predicted by Phobius webserver (Kall et al. 2007). 
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When the relative expression of both isoforms in human prostate tissue was 
studied, both PAP variants were detected in human benign prostatic hyperplasia 
(BPH) and well-differentiated prostate cancer specimens (Figure 9). Evaluation of 
the relative abundance of PAP variants in those specimens by qRT-PCR showed the 
average level of TMPAP transcript variant to be 0.5 ± 0.26 in BPH and 0.45 ± 0.34 
in prostate cancer, while the values corresponding to the SPAP transcript variant 
were 0.60 ± 0.3 and 0.31 ± 0.33, respectively. The expression of both variants was 
observed in all the specimens, but the expression of the secreted variant was 
significantly downregulated in prostate cancer (P < 0.05). 
4.4 PAP localizes to the plasma membrane and to 
subcellular compartments of the endosomal-
lysosomal and exosomal pathway 
The subcellular localization of PAP was studied by immunofluorescence and 
immunoelectron microscopy in cell and tissue samples. The results indicated that, 
in tissue specimens, PAP localizes to vesicles located both at the basal and apical 
cytoplasm, to the lumen of the glands, and to bis-(monoacylglycero) phosphate 
(BMP) containing vesicles (Figure 11A). At higher resolution, IEM results showed 
that PAP localizes to the limiting and internal membranes of apical, electron-
luscent vesicles, as well as to the internal membranes of multivesicular endosomes. 
In agreement with the observations made by immunofluorescence labeling, PAP 
co-localized with BMP in the same structures (Figure 11C). PAP was also observed 
in membranous structures in the lumen of the gland (Figure 11B, left). The 
results in cells showed a similar distribution of PAP in LNCaP cells where PAP was 
observed in endosome-like vesicles and lysosomes (Figure 12A). In the mouse 
Figure 9. Expression of TM-PAP in different mouse cells and tissues, human prostate 
cancer cells, and benign prostatic hyperplasia (BPH) and prostate cancer (PC) patient 
samples. Reprinted by permission from the American Association for Cancer Research: 
Quintero et al., Prostatic Acid Phosphatase Is Not a Prostate Specific Target, Cancer 
Research, 2007, 67: (14), 6549-54. 
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Schwann cells, PAP was observed in the plasma membrane segments and filopodia-
like structures (Figure 12B) where as in the skeletal muscle fibers PAP expression 
was present in the sarcolemma (Figure 10A). Furthermore, the expression 
distribution of a TMPAP-GFP construct was analyzed by confocal microscopy in 
PC3 cells—a prostate cancer cell line that do not express endogenous PAP. The 
TMPAP-GFP was observed in the plasma membrane and in intracellular vesicles 
(Figure 10B). In empty-vector transfected cells, the signal was evenly distributed 
throughout the cell. In addition, PAP was observed to co-localize with both 
lysosomal-associated membrane proteins (LAMP1 and LAMP2), as well as with 
flotillin-1 [a protein commonly associated to lipid rafts, lysosomes, maturing 
phagosomes, early endosomes and exosomes (Otto & Nichols 2011)] in plasma 
membrane and intracellular vesicles (Figure 10, C and D).  
Human LAP precursor is processed in lysosomes by a sequence of two 
proteolytic events resulting in the trapping of soluble LAP into the lumen of the 
lysosomes (Gottschalk et al. 1989). A comparison between hLAP and hTMPAP 
amino acid sequences reveal no amino acid identities at the protease cleavage sites 
or their neighboring residues (Figure 6).  
Figure 10. (A) TM-PAP localization in 
sarcolemma of human skeletal 
muscle detected by immuno-
histochemistry. (B) Localization of 
TM-PAP-GFP in plasma membrane 
and vesicles of PC-3 cells after 
transfection. (C and D) Co-localization 
of PAP with different cell markers in 
LNCaP cells: PAP co-localized with 
flotillin-1 in small vesicles and in the 
plasma membrane (C), PAP co-
localization with lysosomal associated 
membrane protein-2 (LAMP-2; D). 
White arrows, co-localization sites 
(yellow). Reprinted by permission 
from the American Association for 
Cancer Research: Quintero et al., 
Prostatic Acid Phosphatase Is Not a 
Prostate Specific Target, Cancer 
Research, 2007, 67: (14), 6549-54. 
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4.5 PAP activity accounts for 50% of the total acid 
phosphatase activity in wild-type saliva 
When PAP activity was measured in male C57BL/6J saliva, as the tartrate-
sensitive fraction of the total acid phosphatase activity, the total acid phosphatase 
activity against p-NPP was reduced ca. 50% in the presence of tartrate ion (Article 
II: Figure 1A). This effect remains undetected in saliva samples of PAP-/- male mice 
or wild-type female mice. 
4.6 Male PAP-/- mice secrete more stimulated saliva than 
wild-type mice 
Figure 11. PAP and BMP co-localization in human prostate cancer tissue. (A) PAP was localized 
in vesicles both in the basal and apical cytoplasm, and strong labeling was observed in the 
lumen of the glands. PAP showed an almost complete co-localization with BMP (green, PAP; 
red, BMP; blue, nuclei; yellow, co-localization). (B) In addition, PAP labeling was observed in 
the membranous structures in the lumen. PAP (10-nm gold) co-localized with BMP (5-nm gold; 
arrowheads). Some BMP labeling was also observed in the endosomes (right, arrowheads). (C) 
PAP localized in the limiting and internal membranes of apical, electron-lucent vesicles (black 
arrow). PAP was also observed in the lumen of multivesicular endosomes. AJ, adherent 
junction; L, lumen. Adapted by permission from the American Association for Cancer Research: 
Quintero et al., Prostatic Acid Phosphatase Is Not a Prostate Specific Target, Cancer Research, 
2007, 67: (14), 6549-54. 
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The presence of TMPAP in endosomal-lysosomal/exosomal pathway, and the 
observed interaction of TMPAP with snapin, led to the hypothesis that TMPAP is 
involved in endo/exocytic processes. Therefore, to indirectly test this, the total 
salivation volume (normalized by body weight) was measured in anesthesized male 
and female mice upon stimulation with secretagogues. The results indicated a small 
but statistically significant difference between controls and PAP-/- male mice with 
PAP-/- mice secreting a higher volume of saliva (P = 0.03, n = 15) (Article II: 
Figure 1B). However, no modification of other measured parameters was observed, 
such as; total protein concentration or α-amylase activity (Article II: Figure 1, C 
and D). A non-statistically significant increase was seen in the salivation volume of 
female PAP-/- mice compared to wild-type counterparts. No differences in total 
protein concentration nor α-amylase activity were evident between genotypes 
either. In addition, no statistically significant differences in body weight were 
observed between wild-type and PAP-/- genotype groups of each sex.  
Figure 12. PAP localization in LNCaP and SW10. (A) In LNCaP cells, PAP was detected 
in caveosome-like structures (f100 nm; left), small endosome-like vesicles (f65 nm; 
middle), and lysosomes (right). Left, gold labeling was enhanced by silver just enough 
to make the nanoparticles visible (arrows), to avoid any masking of the structures by 
the precipitate; middle and right, a stronger signal was obtained by longer 
enhancement period. (B) PAP in isolated mouse Schwann cells. PAP was localized in 
the plasma membrane domains and filopodias. Reprinted by permission from the 
American Association for Cancer Research: Quintero et al., Prostatic Acid 
Phosphatase Is Not a Prostate Specific Target, Cancer Research, 2007, 67: (14), 
6549-54. 
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4.7 TMP activity is specific for GCT cells in mouse SMG 
In order to compare the levels of acid phosphatase activity in SMG cryosections 
between wild-type and PAP-/- male mice, TMP, AMP, ADP, and ATP were used as 
substrates. TMP was confirmed as a specific substrate for PAP since staining was 
only observed in GCT cells of SMG wild-type samples (Article II: Figure 3, A and 
C), but it was completely absent in PAP-/- specimens (Article II: Figure 3, B, and 
D). However, 5’-ectonucleotidase activity against AMP was observed in both GCT 
and acinar cells of wild-type samples (Article II: Figure 3, E and G), and only 
remains in acinar cells of PAP-/- specimens (Article II: Figure 3, F and H). No 
activity was observed against ADP nor ATP substrates in any of the specimens 
under experimental conditions. 
4.8 The SMGs of male PAP-/- mice exhibit dysregulation 
of gene and miRNA expression 
To determine the molecular changes associated to the observed functional and 
morphological changes in SMG of PAP-/- mice, an initial microarray screening was 
carried out comparing the SMG of 2-month-old male PAP-/- and wild-type mice. 
The ontological analyses of significant DEGs showed an enrichment of upregulated 
genes associated with cell proliferation (e.g. Mki67, Aurkb and Birc5) along with 
immune response processes (e.g. Irf7, Cxcl9, Ccl3, Ccl4, Ccl8 and Fpr2) in PAP-/- 
mice (Article II: Figure 4 and Table 1). These findings were also confirmed by 
other methods. At first, qRT-PCR analyses revealed changes in expression of Irf7 
and Cxcl9 in good agreement with microarray data (FC = 4.9, P = 0.001, n = 7 and 
FC = 2.5, P = 0.002, n = 7, respectively). Moreover, a query of the INTERFEROME 
database (Rusinova et al. 2013) with the list of DEGs showed that over 40% of the 
genes correspond to interferon regulated genes (IRGs). A co-localization network of 
DEGs also shows a clear separation into two clusters defined by positive regulation 
of cell cycle processes and innate immune response (Article II: Figure 4). 
Subsequently, differential miRNA expression in the SMG of PAP-/- and wild-
type male mice was studied using a next-generation sequencing platform. The 
results indicated that miR-146a is the most significantly upregulated miRNA (FC = 
+1.84). 
4.9 The SMGs of male PAP-/- exhibit an increased cell 
proliferation rate and intense inflammatory changes 
To corroborate the observed upregulation of genes associated with cell 
proliferation in the microarray data, the proliferative and apoptotic status of acinar 
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and GCT cells in SMG of the mice was evaluated. For this purpose, in situ staining 
was performed with an antibody against Ki67—a marker of proliferation that shows 
upregulated transcriptional level in the microarray. The results indicated a 
significant increased proliferation of acinar cells in 6- and 12-months-old PAP-/- 
mice (P < 0.001, n = 4) compared with wild-type mice. Similarly, the apoptotic 
status of the cells was determined by counting the number of positive cells in 
TUNEL-assays. No differences were observed regarding the degree of apoptotic cell 
death between any of the groups at any age (Article II: Figures 5, A and B). A 
similar analysis was conducted to evaluate the proliferative and apoptotic status of 
GCT cells, demonstrating a significantly higher proliferation rate in the GCT cells of 
6-months-old PAP-/- mice (P < 0.001, n = 4). However, the significance 
disappeared at the age of 12-months (Article II: Figure 5C). Moreover, at this age, 
the ratio between the number of acinar cells and the total amount of acinar and 
GCT cells was significantly decreased (P < 0.001, n = 8) in PAP-/- mice, but 
remained constant in wild-type animals (Article II: Figure 6). In addition, in 
order to corroborate the observed upregulation of immune response genes in SMG 
of PAP-/- mice, the degree and type of inflammatory infiltration in the SMG of the 
3-, 6- and 12-months-old wild-type and PAP-/- male-mice were compared. A 
significantly higher degree of lymphocyte infiltration was observed in PAP-/- mice at 
the age of 3 months (average T cell score PAP-/-: 2.0, wild-type: 0.75, P = 0.02, n = 
4). At the age of 6-months, the average T-cell score was still higher but not 
statistically significant (average T cell score PAP-/-: 4.25, wild-type: 3.0, P = 0.06, n 
= 4). At 12-months of age, the lymphocyte infiltration was similar in both intensity 
and distribution between genotypes (average T cell score PAP-/-: 4.75, wild-type: 
4.5), which represented a further increase in the degree of inflammation in wild-
type mice, but an almost stagnant degree in the PAP-/- mice. The results are 
summarized in Article II: Figures 5, 6 and 8. 
4.10 LNCaP cells overexpressing TMPAP grow at slow 
rate and accumulate in the G1 phase 
To further investigate the molecular mechanisms associated with cell cycle 
progression, flow cytometry was employed to analyze LNCaP cells that overexpress 
SPAP, TMPAP, or pMX-empty vector. The results indicated that at 48 h after 
plating, a significantly higher proportion of LNCaP-TMPAP cells (73.7%, P < 0.001) 
accumulated at G1 phase of the cell cycle when compared with LNCaP-pMX (61.3%, 
P < 0.001) and LNCaP-SPAP (57.6%, P < 0.01) cells (Article III: Figure 1).  
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4.11 LNCaP-TMPAP cells show downregulation of 
transferrin receptor and reduced transferrin 
endocytosis 
In order to corroborate if the observed downregulation of transferrin receptor 
gene expression (TFRC-1.66) is also manifested at the functional level, labeled-
transferrin (TF) uptake experiments were performed. LNCaP-TMPAP cells 
exhibited a clear reduction of TF endocytosis when compared with LNCaP-SPAP 
cells. This was demonstrated by a significant reduction of TF bound (B) to the 
plasma membrane of LNCaP-TMPAP cells compared to LNCaP-SPAP (P = 0.006, n 
= 15) or LNCaP-pMX (P = 0.04, n = 15) at +4°C. After the cells were incubated at 
+37°C for 30 min, the amount of TF (B+E) remained significantly lower in LNCaP-
TMPAP cells compared with LNCaP-SPAP (P = 2.2×10-5, n1 = 15, n2 = 12, 
respectively) or LNCaP-pMX (P = 0.03, n = 15). The results are summarized in 
(Article III: Figure 2 and Table 1). 
4.12 LNCaP-TMPAP and LNCaP-SPAP cells show 
increased HRP uptake and cell size 
The overexpression of SPAP or TMPAP is hypothesized to lead to an increase in 
endo/exocytic processes that would manifest as differences in cell area as a 
consequence of the insertion and removal of vesicular membranous material. The 
cell surface area approximately measured from a 2D-projection area is in good 
agreement with this hypothesis. As expected, both LNCaP-SPAP (828±80 μm2) and 
LNCaP-TMPAP (767±97 μm2) cells are significantly bigger in size compared with 
empty-vector transfected cells (589±20 μm2) (P=7.7×10-10, n1=46, n2=175 and 
P=3.6×10-3, n1=66, n2=175, respectively) (Article III: Figure 4). 
4.13 LNCaP cells overexpressing TMPAP show 
dysregulated gene expression 
Differences in cell growth were evident between LNCaP-TMPAP cells and 
LNCaP-pMX cells, but not between LNCaP-SPAP cells and LNCaP-pMX cells. 
Therefore, microarray analysis was conducted in order to identify dysregulated 
genes that could explain the observations. The ontological analyses of DEGs 
revealed that the overrepresented ontological groups related to cell cycle included 
a large group of downregulated histone genes from families H1, H2A and H2B 
(Article III: Supl. tables 1 and 2). Other DEGs observed in microarray data were 
the transferrin receptor TFRC(-1.66) and the adenosine receptors ADORA1(-1.47), 
ADORA2A(-1.91), ADORA2B(-2.05) and ADORA3(-1.59). The microarray data were 
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validated by qRT-PCR on selected genes and the results showed good agreement 
with the observed expression values in microarrays: H2AFJ (FC=-8.17, P=0.002), 
CDK6 (FC=-4.45, P=0.001), ADORA2A(FC=-1.84, P=0.02), IGFBP3 (FC=+4.22, 
P=0.0003) and TFRC (FC=-1.47, P=0.02). 
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5 DISCUSSION 
Prostatic acid phosphatase (PAP) has been known for 70 years in its soluble 
secreted form as an enzyme that is highly expressed in human prostate. This led to 
the conception that it is a prostate-specific enzyme up to the point that it could be 
considered a prostate-specific antigen suitable for the development of 
immunotherapies against prostate cancer (Kantoff et al. 2010; Cheever & Higano 
2011). The existence of an extracellular soluble isoform of PAP led some 
researchers to postulate the hypothesis of the existence of a cytosolic isoform 
(cPAP) derived from the soluble form and capable of dephosphorylating the ErbB2 
receptor (Meng & Lin 1998; Veeramani et al. 2005; Chuang et al. 2010). However, 
during the course of this investigation, a novel transmembrane type-I isoform of 
PAP (TMPAP) was identified that localizes to the plasma membrane and to the 
endosomal-lysosomal pathway and consequently it fails to match the 
characteristics of cPAP, which was never sequenced. Therefore, animal and cell 
models were characterized here in order to establish a functional molecular 
framework to discuss the molecular context in which TMPAP should be considered 
in future research. 
5.1  TMPAP traffics to the lysosomes by means of its 
Yxxφ motif 
Soluble lysosomal hydrolases are delivered to the lysosomes by a direct route 
from the TGN and involves the M6PR pathway (von Figura & Hasilik 1986). 
However, membrane-associated hydrolases such as LAP are delivered to the 
lysosomes through an indirect pathway that involves the plasma membrane and the 
clathrin-dependent endocytic route (Braun et al. 1989). In the case of LAP, it 
recycles through the plasma membrane and the lysosomes several times until it 
gets trapped into the lumen of the lysosomes by a proteolytic cleavage (Gottschalk 
et al. 1989). The topological arrangement of signal peptide and transmembrane 
segment of TMPAP precursor resemble those of the lysosomal acid phosphatase 
(LAP) and lysosomal associated-membrane glycoproteins (LAMPs). The presence 
of the Yxxφ motif is sufficient for lysosomal localization of proteins when additional 
constraints are met.  These constraints include the distance between the tyrosine 
residue and the TM segment (Rohrer et al. 1996), the localization of the tyrosine-
based motif at the C-terminal end of the sequence (Bonifacino & Traub 2003), and 
the nature of the bulky hydrophobic residue (Gough et al. 1999). In TMPAP, all of 
these additional constraints are satisfied. Other endocytic cargoes with a tyrosine-
based motif that are not destined to lysosomes—e.g. transferrin receptor—carry an 
inner Yxxφ motif (Bonifacino & Traub 2003).   
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The cellular localization studies confirmed that TMPAP-GFP is present in the 
plasma membrane and intraluminal vesicles of MVE (Article I), as well as the 
exosomes (Quintero et al. 2013), whereas the signal was evenly distributed 
throughout the cell in the empty-vector transfected cells. In addition, TMPAP-GFP 
co-localized with LAMP2 protein which is a typical marker for lysosomes (Article 
I). An illustration of the proposed mechanism for the intracellular trafficking of 
TMPAP is depicted in Figure 13. 
5.2 TMPAP endocytosis regulates cell cycle progression 
in LNCaP cells  
The overexpression of TMPAP or SPAP was studied in LNCaP cells in order to 
discriminate between the effects on endo/exocytosis produced by each isoform. 
Consequently, the overexpression of TMPAP but not SPAP produces an increased 
endo/exocytosis with a concomitant delay at the G1/S phase of the cell cycle. 
Changes at the transcriptional level were observed, in line with observations. 
LNCaP-TMPAP cells show differences in cell cycle progression that are 
independent of their shared 5’-ectonucleotidase activity; both PAP isoforms carry 
Figure 13. A proposed trafficking mechanism for TMPAP. Ado: adenosine, TGN: trans-Golgi 
network, P: phosphate group, AP-2: adaptor protein complex 2, AC: adenylate cyclase, G-prot: 
trimeric G-protein, PKA: protein kinase A, AMP: adenosine monophosphate, cAMP: cyclic adenosine 
monophosphate, VDCC: Voltage-dependent calcium channel. Green dotted-lines represent clathrin-
coat. Adapted from Quintero, IB et al. Transmembrane Prostatic Acid Phosphatase (TMPAP) 
Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma. PLoS One, 2013, 
8(9):e73072.  
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an identical extracellular N-terminus. Overall, the observed differences can be 
explained by the transmembrane type-I nature of TMPAP and the presence of a 
tyrosine-based motif at the C-terminus (Article III).  
The observed changes at the gene-expression level in LNCaP-TMPAP cells are 
compatible with a delay in G1/S cell-cycle phase and with a dysregulated 
endo/exocytic process. The downregulation of histones and CDK6 can explain the 
retarded cell cycle. In addition, the extracellular adenosine pathway appears to be 
affected by the downregulation of adenosine receptors (ADORA1, ADORA2A, 
ADORA2B, and ADORA3) and adenosine kinase (ADK). These changes can be 
explained after considering that the increased expression of TMPAP results in an 
increased extracellular 5’-ectonucleotidase activity (Article III). 
In the proposed mechanistic model the endocytic vesicles loaded with TMPAP 
are sorted to lysosomes by means of the Yxxφ motif. Consequently other cargo 
molecules carried by TMPAP-loaded vesicles are targeted for degradation. This can 
serve as an alternate mechanism of degradation for those cell surface receptors 
(such as RTKs or GPCR) that fail to follow the canonical monoubiquitination 
pathway. Moreover, the presence of TMPAP in the exosomes of LNCaP cells 
(Quintero et al. 2013) can be another alternative cellular mechanism to 
downregulate cell surface signaling receptors (Article III). 
5.3 PAP serves specific function in male mouse SMG and 
saliva 
The balance between exo- and endocytosis controls the cell membrane 
homeostasis and other cellular processes such as cell division. We also found that 
TMPAP interacts with snapin that is a SNARE-associated protein and PAP-/- mice 
developed prostate adenocarcinoma (Quintero et al. 2013). In addition, snapin is a 
component of BLOC1—a complex required for the biogenesis of specialized 
organelles of the endosomal-lysosomal pathway. Therefore, by considering that 
TMPAP is in the endosomal-lysosomal/exosomal pathway we decided to study the 
SMGs of PAP-/- and wild-type mice as a model of exocrine organ. In mice, PAP 
accounts for 50% of the total acid phosphatase activity in male saliva whereas 
female saliva lacks PAP activity (Article II). In male wild-type mice, PAP activity 
exclusively localizes to the GCT cells. Moreover, under the reported experimental 
conditions, PAP is the only 5’-ectonucleotidase expressed in GCT cells (Article II) 
whereas there are other 5’-ectonucleotidases present in acinar cells such as Cd73 
(Nt5e) (Lavoie et al. 2011). Another parameter to consider is the pH of the saliva. 
According to the literature, the pH of the C57BL/6J male-mouse saliva lies in the 
range 8.0 to 11.0 (Ma et al. 1999; Ruiz-Ederra et al. 2009). In mammals, the high 
pH of saliva is required to prevent the formation of dental caries (Catalan et al. 
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2011). In vitro studies showed that PAP is an active enzyme in a pH range from 4.0 
to 8.0 (Van Etten 1982). This raises the question as to why, in mouse SMGs, PAP is 
only expressed by a subset of specialized secretory cells (GCTs) that are fully 
developed only in males and in a fluid with a pH range where PAP is inactive. In 
order to understand this question, what is known about the physiological role of 
PAP must be considered. This pioneering characterization of the TMPAP isoform 
(Article I) led to the discovery that PAP participates in nociceptive mechanisms. 
Zylka et al., demonstrated that PAP exerts a systemic analgesic effect in mouse 
models of chronic inflammatory pain (Zylka et al. 2008). Moreover, soluble PAP 
can elicit local analgesic effect in acupuncture points without requiring needle 
stimulation (Hurt & Zylka 2012).  Hence, the presence of PAP in male-mouse saliva 
is likely to fulfill sex-specific requirements. Therefore, the 5’-ectonucleotidase 
activity of PAP can elicit a pain-relief effect when the animals lick their wounds 
inflicted on them after a fight for food and territory (Article II and Figure 14).  
 A sustained increased acinar cell proliferation was seen in PAP-/- SMGs in vivo, 
without concomitant manifestation of glandular hyperplasia. Moreover, the ratio 
between the acinar cells and the number of total cells in the glands remained 
constant at 3 and 6-months of age and is significantly reduced at 12-months of age. 
This is in contrast with the observed development of prostate adenocarcinoma in 
Figure 14. Prostatic acid phosphatase (PAP) signaling in salivary glands and saliva. Adapted 
from Weissman, G.A., Why do male mice spit soluble enzymes that hydrolyze extracellular 
nucleotides? An Editorial Focus on Article II: “Prostatic acid phosphatase is the main acid 
phosphatase with 5’-ectonucleotidase activity in the male mouse saliva and regulates 
salivation , Am J Physiol Cell Physiol, 2014, 306: C997-C998. 
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PAP-/- mice (Quintero et al. 2013). To understand this phenomenon at the 
molecular level, microarray and microRNA experiments were performed on SMG 
tissue from 2-month-old wild-type and PAP-/- mice. They demonstrated an 
upregulation of genes related to cell proliferation and immune system response. In 
addition, miR-146a—an important regulator of inflammation—was upregulated. 
Thus, a histological evaluation of the glands was made. The results indicated 
significantly increased lymphocyte infiltration in 3-month-old mice that reached a 
plateau from 6 to 12-months of age. The increased acinar cell proliferation at 2-
month-of-age occurs concomitantly with the upregulation of inflammatory and 
immune system genes. Consequently, the immune reaction is likely responsible for 
keeping the proliferative acinar cells under control. In addition, the upregulation of 
mir-146a and pro-resolving inflammatory genes, such as Irf7 and Fpr2, may be 
responsible for avoiding extensive tissue damage that otherwise should occur as a 
consequence of the increased T-lymphocyte infiltration as observed in mouse 
models of autoimmune diseases (e.g. Sjögren’s syndrome) (Varin et al. 2012). 
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6 CONCLUSIONS AND FUTURE 
PERSPECTIVES 
This work reveals new fundamental clues regarding the molecular pathways 
where PAP is involved. During the characterization of the novel TMPAP isoform its 
localization in the endosomal/lysosomal and exosomal route was predicted. These 
predictions were experimentally confirmed and led to the formulation of a 
mechanistic working model that opens new avenues of research. For instance, it led 
to the final characterization of TMPase—a hitherto uncharacterized enzyme 
involved in mechanisms of nociception—and placed PAP into the realm of 5’-
ectonucleotidases and pain signaling. In addition, it was observed that a virally-
driven overexpression of TMPAP in the rostral ventrolateral medulla oblongata led 
to a significant reduction in arterial blood pressure in rats—an effect attributed to 
the 5’-ectonucleotidase activity (Marina et al. 2015). By studying the mouse SMG as 
a model of exocrine organ the presence of PAP in male mouse saliva was concluded 
to be required to support sex-specific requirements related to the antinociceptive 
effect elicited by the 5’-ectonucleotidase activity on wounds. The lack of PAP 
expression in male mice SMG also fails to compromise either the innate immune 
response against highly proliferative cells or the pro-resolving anti-inflammatory 
processes responsible to keep tissue homeostasis. This is an important difference 
with the observed development of adenocarcinoma in the prostate—an 
immunologically ignored organ (Bruno et al. 2012). Furthermore, TMPAP, but not 
SPAP, regulates LNCaP cell proliferation and this led to the conclusion that this 
effect is associated to the presence of TMPAP in the endocytic pathway. Therefore, 
future retrospective studies will bring explanations of many observations that could 
not be explained by considering only the secreted isoform of PAP. For instance, the 
radio-imaging detection of metastatic lesions observed by Vihko et al. about 30 
years ago, which can be a valuable tool for diagnosis (Kontturi et al. 1988).  In 
addition, the presence of TMPAP in the endosomal-lysosomal/exosomal pathway 
could be exploited by drug delivery protocols. Moreover, PAP can become a 
fundamental therapeutic tool for the management of neuropathic pain, which is a 
common co-morbidity of many diseases, including metastatic prostate cancer.  
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